Question-and-Answer Session
Operator
(Operator Instructions). Your first question comes from the line of Brooks O'Neil with Dougherty & Company.
Brooks O'Neil - Dougherty & Company
I have a couple of questions. I guess I might as well start with one of the hotter topics I guess we are all aware that the Board received a letter from Clay Dunnagan earlier this week, and I am just curious if you could comment on the board's consideration of that letter?
Rich Friedman
We received a letter, as everyone is aware. BioScrip and the board are committed to enhancing and maximizing shareholder value. All responsible letters we receive, whether it's to the board or management from significant shareholders, that contain recommendations about the company's strategy or operations, are in fact refer to the board or the appropriate committees of the board, and all are being considered and when indicated, we will take action and a response.
In fact, Anchor's request letter was forwarded to the company's corporate strategy committee, and later today the company intends to respond to Anchor, and after due consideration the committee has determined that it is in the company's and stockholders best interest to continue to pursue our growth strategy, as well as its efforts to further reduce costs and build on our recent improvements in operating efficiency.
We have put the team in place, we have taken out significant costs, and we believe it's a best strategy to follow this road.
Brooks O'Neil - Dougherty & Company
I am curious, one of the things that the letter highlighted and one of the things that we've talked about over a period of time is the need to balance the opportunities for growth with a very clear need to enhance your profit margins.
I am pleased to see the beginning of some improvement in the gross margin this quarter and continued tight expense control. I am just curious, as you think about the improving cash flow dynamics of the business, how do you think about using that cash flow in terms of growth or do you leveraging or whatever?
Rich Friedman
Well, first of all. and we'll let Rick take this up in the second. Our expansion plans are clearly aimed towards the infusion business, the infusion therapies, as well as the expansion of the community stores.
We really believe that the assets that we have put in place, meet exactly what is happening in this country today, which is the access to quality and the cost controls, and we need to expand our clinical programs we're putting in, a state-of-the-art enterprise system. We have brought in the people that have the experience to execute on this strategy.
- To read the full transcript on Seeking Alpha, click here »
